Christian Bernard Matthijs Poulie

Guest Researcher

Publication year:

All

1 - 2 out of 2Page size: 25

Sort by: Publication date

2024
Published
Development and Preclinical Evaluation of [²¹¹At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer.
El Fakiri, M., Ayada, N., Müller, Marius, Hvass, Lars, Gamzov, T. H., Clausen, Anne Skovsbo, Geis, N. M., Steinacker, N., Hansson, E., Lindegren, S., Aneheim, E., Jensen, H., Eder, A., Jensen, Andreas, Poulie, Christian Bernard Matthijs, Kjær, Andreas, Eder, M. & Herth, Matthias Manfred, 2024, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 65, 4, p. 593-599
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Development of a ^99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model
Bohrmann, L., Poulie, Christian Bernard Matthijs, Rodríguez-Rodríguez, C., Karagiozov, S., Saatchi, K., Herth, Matthias Manfred & Häfeli, U. O., 2024, In: PLoS ONE. 19, 4, 18 p., e0300466.
Research output: Contribution to journal › Journal article › Research › peer-review

ID: 43877477

75 downloads
One-step synthesis of N-succinimidyl-4-[¹⁸F]Fluorobenzoate ([¹⁸F]SFB)
Research output: Contribution to journal › Journal article › Research › peer-review
Published
36 downloads
Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT_2A Receptor Agonists
Research output: Contribution to journal › Journal article › Research › peer-review
Published
34 downloads
Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted In Vivo Chemistry
Research output: Contribution to journal › Journal article › Research › peer-review
Published

Department of Drug Design and Pharmacology